Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - azathioprin - filmovertrukne tabletter - 50 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

silver pharma s.l. - mercaptopurin - tabletter - 50 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - mercaptopurin - tabletter - 50 mg

Unione Europea - danese - EMA (European Medicines Agency)

viiv healthcare bv - lamivudin, zidovudin - hiv infektioner - antivirale midler til systemisk anvendelse - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.

Unione Europea - danese - EMA (European Medicines Agency)

teva pharma b.v.  - lamivudin, zidovudin - hiv infektioner - antivirale midler til systemisk anvendelse - lamivudin / zidovudin teva er indiceret i antiretroviral kombinationsbehandling til behandling af hiv-infektion (human immunodeficiency virus).

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - azathioprin - filmovertrukne tabletter - 25 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - azathioprin - filmovertrukne tabletter - 50 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

viiv healthcare bv - zidovudin - kapsler, hårde - 250 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

viiv healthcare bv - zidovudin - oral opløsning - 10 mg/ml

Unione Europea - danese - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - purpura, trombocytopenisk, idiopatisk - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.